New York State Common Retirement Fund
VIR icon

New York State Common Retirement Fund’s Vir Biotechnology VIR Stock Holding History

New York State Common Retirement Fund’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Buy
43,106
+18,500
+75% +$176K ﹤0.01% 2058
2026
Q1 		$220K Hold
24,606
– – ﹤0.01% 2201
2025
Q4 		$148K Hold
24,606
– – ﹤0.01% 2424
2025
Q3 		$141K Sell
24,606
-40,300
-62% -$206K ﹤0.01% 2454
2025
Q2 		$327K Hold
64,906
– – ﹤0.01% 2057
2025
Q1 		$421K Hold
64,906
– – ﹤0.01% 1938
2024
Q4 		$476K Buy
64,906
+40,300
+164% +$318K ﹤0.01% 1955
2024
Q3 		$184K Sell
24,606
-9,400
-28% -$81.6K ﹤0.01% 2339
2024
Q2 		$303K Buy
34,006
+706
+2% +$6.77K ﹤0.01% 2250
2024
Q1 		$337K Sell
33,300
-743
-2% -$7.57K ﹤0.01% 2230
2023
Q4 		$342K Sell
34,043
-339
-1% -$3.1K ﹤0.01% 2242
2023
Q3 		$322K Sell
34,382
-10,618
-24% -$151K ﹤0.01% 2227
2023
Q2 		$1.1M Buy
45,000
+6,865
+18% +$172K ﹤0.01% 1733
2023
Q1 		$887K Sell
38,135
-38,585
-50% -$987K ﹤0.01% 1908
2022
Q4 		$1.94M Buy
76,720
+1,779
+2% +$43.6K ﹤0.01% 1657
2022
Q3 		$1.45M Sell
74,941
-4,654
-6% -$118K ﹤0.01% 1774
2022
Q2 		$2.03M Buy
79,595
+36,278
+84% +$847K ﹤0.01% 1650
2022
Q1 		$1.11M Buy
43,317
+27
+0.1% +$801 ﹤0.01% 2058
2021
Q4 		$1.81M Sell
43,290
-132
-0.3% -$5.17K ﹤0.01% 1828
2021
Q3 		$1.89M Sell
43,422
-8,536
-16% -$370K ﹤0.01% 1787
2021
Q2 		$2.46M Buy
51,958
+3,458
+7% +$157K ﹤0.01% 1742
2021
Q1 		$2.49M Hold
48,500
– – ﹤0.01% 1661
2020
Q4 		$1.3M Hold
48,500
– – ﹤0.01% 1912
2020
Q3 		$1.67M Buy
48,500
+6,000
+14% +$258K ﹤0.01% 1666
2020
Q2 		$1.74M Buy
42,500
+34,300
+418% +$1.15M ﹤0.01% 1590
2020
Q1 		$281K Hold
8,200
– – ﹤0.01% 2299
2019
Q4 		$103K Buy
+8,200
New +$110K ﹤0.01% 2999

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

New York State Common Retirement Fund's VIR Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Vir Biotechnology (VIR) stake by 75% in Q2 2026, buying an estimated $176K and bringing the position to 43,106 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

New York State Common Retirement Fund first reported a position in VIR in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.49M in Q1 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • New York State Common Retirement Fund held 43,106 shares of Vir Biotechnology worth $439K as of Q2 2026.
  • New York State Common Retirement Fund bought 18,500 Vir Biotechnology shares in Q2 2026, an estimated $176K.
  • Vir Biotechnology made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2058 holding.
  • New York State Common Retirement Fund first reported a position in Vir Biotechnology in Q4 2019 and has held it in 27 quarters since.
  • New York State Common Retirement Fund's Vir Biotechnology position peaked at $2.49M in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.